{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:16:11Z","timestamp":1782522971269,"version":"3.54.5"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG073823; RF1 AG082388"],"award-info":[{"award-number":["R01 AG073823; RF1 AG082388"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The apolipoprotein E type \u220a4 allele (ApoE4) is known as the strongest genetic risk factor for Alzheimer\u2019s Disease (AD). Meanwhile, many aspects of its impact on AD pathology remain underexplored. This study conducts a systematic data analysisof donor data from the Seattle Alzheimer\u2019s Disease Brain Cell Atlas. Our investigation delves into the intricate interplay between identified biomarkers and their correlation with ApoE4 across all severities of AD. Employing Pearson R correlation, and one-way and two-way ANOVA tests, we elucidate the pathological changes in biomarkers and the altering effects of ApoE4. Remarkably, the phosphorylation of tau observed in neurofibrillary tangles (NFTs) marked by the AT8 antibody, emerges as the most correlated factor with other pathological biomarkers. This correlation is mediated by both tau and amyloid pathology, suggesting a higher hierarchical role in determining AD pathological effects than other biomarkers. However, non-ApoE4 carriers exhibit a more significant correlation with disease progression severity compared to ApoE4 carriers, though ApoE4 carriers demonstrate significance in exacerbating the effect of accumulating phosphorylated tau and amyloid plaques assessed by AT8 and 6E10 antibodies. Furthermore, our analysis does not observe dramatic neuronal changes in grey matter across the span of AD pathology. Glia activation, measured by Iba1 and GFAP, demonstrates an amyloid-specific correlation. This research marks the first human post-mortem analysis providing a comprehensive examination of prevailing AD biomarkers and their interconnectedness with pathology and ApoE4 genetic factor. Limitations in the study are acknowledged, underscoring the need for further exploration and refinement in future research endeavors.<\/jats:p>","DOI":"10.1371\/journal.pone.0303486","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T19:02:56Z","timestamp":1738868576000},"page":"e0303486","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["The impact of apolipoprotein E, type \u220a4 allele on Alzheimer\u2019s disease pathological biomarkers: a comprehensive post-mortem pilot-analysis"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2443-6435","authenticated-orcid":true,"given":"Ziyu","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0763-7261","authenticated-orcid":true,"given":"Tao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"issue":"8","key":"pone.0303486.ref001","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease","volume":"43","author":"AM Saunders","year":"1993","journal-title":"Neurology"},{"issue":"5","key":"pone.0303486.ref002","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A quarter century of APOE and Alzheimer\u2019s disease: progress to date and the path forward","volume":"101","author":"ME Belloy","year":"2019","journal-title":"Neuron"},{"issue":"16","key":"pone.0303486.ref003","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis","volume":"278","author":"L Farrer","year":"1997","journal-title":"JAMA"},{"issue":"5123","key":"pone.0303486.ref004","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"EH Corder","year":"1993","journal-title":"Science"},{"issue":"5","key":"pone.0303486.ref005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00109-018-1632-y","article-title":"Cell-specific production, secretion, and function of apolipoprotein E","volume":"96","author":"M Kockx","year":"2018","journal-title":"J Mol Med"},{"issue":"3","key":"pone.0303486.ref006","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/JMN:23:3:189","article-title":"Apolipoprotein E","volume":"23","author":"Y Huang","year":"2004","journal-title":"J Mol Neurosci"},{"issue":"19","key":"pone.0303486.ref007","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus","volume":"26","author":"Q Xu","year":"2006","journal-title":"J Neurosci"},{"issue":"8","key":"pone.0303486.ref008","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/mp.2010.57","article-title":"Molecular signatures in post-mortem brain tissue of younger individuals at high risk for Alzheimer\u2019s disease as based on APOE genotype","volume":"16","author":"C Conejero-Goldberg","year":"2011","journal-title":"Mol Psychiatry"},{"issue":"2","key":"pone.0303486.ref009","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0694-180","article-title":"Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease","volume":"7","author":"EH Corder","year":"1994","journal-title":"Nat Genet"},{"issue":"1","key":"pone.0303486.ref010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13024-022-00566-4","article-title":"APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer\u2019s disease pathology and brain diseases","volume":"17","author":"R Fern\u00e1ndez-Calle","year":"2022","journal-title":"Mol Neurodegener"},{"issue":"7","key":"pone.0303486.ref011","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1007\/s10571-023-01365-1","article-title":"Roles of ApoE4 on the pathogenesis in Alzheimer\u2019s disease and the potential therapeutic approaches","volume":"43","author":"YY Sun","year":"2023","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"pone.0303486.ref012","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1073\/pnas.0904532106","article-title":"Mechanism of amyloid plaque formation suggests an intracellular basis of A\u03b2 pathogenicity","volume":"107","author":"RP Friedrich","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0303486.ref013","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"A Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb Perspect Med"},{"key":"pone.0303486.ref014","first-page":"1","article-title":"A\u03b2 Plaques","volume":"1","author":"LC Walker","year":"2020","journal-title":"Free Neuropathol"},{"key":"pone.0303486.ref015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bios.2015.05.017","article-title":"Label-free detection of ApoE4-mediated \u03b2-amyloid aggregation on single nanoparticle uncovering Alzheimer\u2019s disease","volume":"72","author":"MK Kang","year":"2015","journal-title":"Biosens Bioelectron"},{"issue":"4","key":"pone.0303486.ref016","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and A\u03b2 in Alzheimer\u2019s disease: accidental encounters or partners?","volume":"81","author":"T Kanekiyo","year":"2014","journal-title":"Neuron"},{"issue":"12","key":"pone.0303486.ref017","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.tins.2014.08.004","article-title":"Lost after translation: missorting of Tau protein and consequences for Alzheimer disease","volume":"37","author":"H Zempel","year":"2014","journal-title":"Trends Neurosci"},{"issue":"10","key":"pone.0303486.ref018","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein E4 proteolysis is associated with increased Tau phosphorylation in brains of transgenic mice","volume":"24","author":"WJ Brecht","year":"2004","journal-title":"J Neurosci"},{"issue":"12","key":"pone.0303486.ref019","doi-asserted-by":"crossref","first-page":"e0271707","DOI":"10.1371\/journal.pone.0271707","article-title":"An amino-terminal fragment of apolipoprotein E4 leads to behavioral deficits, increased PHF-1 immunoreactivity, and mortality in zebrafish","volume":"17","author":"MM McCarthy","year":"2022","journal-title":"PLoS One"},{"issue":"7673","key":"pone.0303486.ref020","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy","volume":"549","author":"Y Shi","year":"2017","journal-title":"Nature"},{"key":"pone.0303486.ref021","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2015.09.011","article-title":"Association of APOE with tau-tangle pathology with and without \u03b2-amyloid","volume":"37","author":"JM Farfel","year":"2016","journal-title":"Neurobiol Aging"},{"key":"pone.0303486.ref022","doi-asserted-by":"crossref","first-page":"134285","DOI":"10.1016\/j.neulet.2019.134285","article-title":"The role of APOE in transgenic mouse models of AD","volume":"707","author":"D Balu","year":"2019","journal-title":"Neurosci Lett"},{"key":"pone.0303486.ref023","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-018-06783-0","article-title":"ApoE \u03b52 is associated with increased tau pathology in primary tauopathy","volume":"9","author":"N Zhao","year":"2018","journal-title":"Nature Comm"},{"issue":"11","key":"pone.0303486.ref024","doi-asserted-by":"crossref","first-page":"e20200861","DOI":"10.1084\/jem.20200861","article-title":"Blood plasma phosphorylated-tau isoforms track CNS change in Alzheimer\u2019s disease","volume":"217","author":"NR Barth\u00e9lemy","year":"2020","journal-title":"J Exp Med"},{"issue":"1","key":"pone.0303486.ref025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-023-00605-8","article-title":"Plasma phospho-tau in Alzheimer\u2019s disease: towards diagnostic and therapeutic trial applications","volume":"18","author":"F Gonzalez-Ortiz","year":"2023","journal-title":"Mol Neurodegener"},{"issue":"2","key":"pone.0303486.ref026","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41380-020-00923-z","article-title":"Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer\u2019s disease neuroimaging initiative","volume":"26","author":"TK Karikari","year":"2021","journal-title":"Mol Psychiatry"},{"issue":"8","key":"pone.0303486.ref027","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma phospho-tau181 increases with Alzheimer\u2019s disease clinical severity and is associated with tau- and amyloid-positron emission tomography","volume":"14","author":"MM Mielke","year":"2018","journal-title":"Alzheimers Dement J Assoc"},{"issue":"1","key":"pone.0303486.ref028","first-page":"1","article-title":"Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer\u2019s amyloid, tau and FDG PET status","volume":"11","author":"XN Shen","year":"2021","journal-title":"Transl Psychiatry"},{"key":"pone.0303486.ref029","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/978-981-32-9358-8_29","article-title":"Cerebrospinal fluid and plasma tau as a biomarker for brain tauopathy","author":"M Shoji","year":"2019","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"pone.0303486.ref030","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","article-title":"ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies","volume":"17","author":"AC Raulin","year":"2022","journal-title":"Mol Neurodegener"},{"issue":"2","key":"pone.0303486.ref031","doi-asserted-by":"crossref","first-page":"202\u201319.e7","DOI":"10.1016\/j.neuron.2022.10.022","article-title":"TREM2-independent microgliosis promotes tau-mediated neurodegeneration in the presence of ApoE4","volume":"111","author":"M Gratuze","year":"2023","journal-title":"Neuron"},{"issue":"3","key":"pone.0303486.ref032","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3233\/JAD-180582","article-title":"Epitomic characterization of the specificity of the anti-amyloid A\u03b2 monoclonal antibodies 6E10 and 4G8","volume":"66","author":"I Baghallab","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"pone.0303486.ref033","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","article-title":"Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer\u2019s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease","volume":"541","author":"Y Namba","year":"1991","journal-title":"Brain Res"},{"key":"pone.0303486.ref034","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-pathmechdis-030421-112756","article-title":"Apolipoprotein E and Alzheimer\u2019s disease: findings, hypotheses, and potential mechanisms","volume":"17","author":"N Koutsodendris","year":"2022","journal-title":"Annu Rev Pathol"},{"issue":"5","key":"pone.0303486.ref035","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000100926","article-title":"Prediction of Alzheimer\u2019s disease using the CSF A\u03b242\/A\u03b240 ratio in patients with mild cognitive impairment","volume":"23","author":"O Hansson","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"pone.0303486.ref036","first-page":"CD010803","article-title":"CSF tau and the CSF tau\/ABeta ratio for the diagnosis of Alzheimer\u2019s disease dementia and other dementias in people with mild cognitive impairment (MCI)","author":"C Ritchie","year":"2017","journal-title":"Cochrane Database of Syst Rev"},{"issue":"3","key":"pone.0303486.ref037","first-page":"CD010783","article-title":"Mini-Mental State Examination (MMSE) for the detection of Alzheimer\u2019s disease and other dementias in people with mild cognitive impairment (MCI)","author":"I Arevalo-Rodriguez","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"pone.0303486.ref038","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S1041610294001602","article-title":"The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia","volume":"6","author":"EL Teng","year":"1994","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"pone.0303486.ref039","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","article-title":"Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease","volume":"11","author":"JW Vogel","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"pone.0303486.ref040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s40478-022-01359-y","article-title":"Impact of APOE genotype on prion-type propagation of tauopathy","volume":"10","author":"T Williams","year":"2022","journal-title":"Acta Neuropathol Commun"},{"issue":"338","key":"pone.0303486.ref041","doi-asserted-by":"crossref","first-page":"338ra66","DOI":"10.1126\/scitranslmed.aaf2362","article-title":"Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer\u2019s disease","volume":"8","author":"MR Brier","year":"2016","journal-title":"Sci Transl Med"},{"issue":"7638","key":"pone.0303486.ref042","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"SA Liddelow","year":"2017","journal-title":"Nature"},{"key":"pone.0303486.ref043","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1742-2094-8-150","article-title":"The contribution of activated astrocytes to A\u03b2 production: implications for Alzheimer\u2019s disease pathogenesis","volume":"8","author":"J Zhao","year":"2011","journal-title":"J Neuroinflammation"},{"issue":"14","key":"pone.0303486.ref044","doi-asserted-by":"crossref","first-page":"e169131","DOI":"10.1172\/JCI169131","article-title":"ApoE-\u03b54 synergizes with sleep disruption to accelerate A\u03b2 deposition and A\u03b2-associated tau seeding and spreading","volume":"133","author":"C Wang","year":"2023","journal-title":"J Clin Invest"},{"issue":"529","key":"pone.0303486.ref045","doi-asserted-by":"crossref","first-page":"eaay1809","DOI":"10.1126\/scitranslmed.aay1809","article-title":"APOE4 exacerbates \u03b1-synuclein pathology and related toxicity independent of amyloid","volume":"12","author":"N Zhao","year":"2020","journal-title":"Sci Transl Med"},{"key":"pone.0303486.ref046","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neurobiolaging.2020.06.004","article-title":"Hyperexcitability and seizures in the THY-Tau22 mouse model of Tauopathy","volume":"94","author":"V Gomez-Murcia","year":"2020","journal-title":"Neurobiol Aging"},{"key":"pone.0303486.ref047","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neurobiolaging.2021.09.006","article-title":"Pathological tau and reactive astrogliosis are associated with distinct functional deficits in a mouse model of tauopathy","volume":"109","author":"H Patel","year":"2022","journal-title":"Neurobiol Aging"},{"issue":"12","key":"pone.0303486.ref048","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1212\/WNL.57.12.2223","article-title":"Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women","volume":"57","author":"RM Cohen","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"pone.0303486.ref049","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neulet.2010.05.092","article-title":"Cortical thickness is associated with different apolipoprotein E genotypes in healthy elderly adults","volume":"479","author":"M Fan","year":"2010","journal-title":"Neurosci Lett"},{"issue":"9","key":"pone.0303486.ref050","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.biopsych.2013.11.032","article-title":"Ptau-A\u03b242 ratio as a continuous trait for biomarker discovery for early stage Alzheimer\u2019s disease in multiplex immunoassay panels of cerebrospinal fluid","volume":"75","author":"O Harari","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"12","key":"pone.0303486.ref051","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of a beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"DR Thal","year":"2002","journal-title":"Neurology"},{"issue":"3","key":"pone.0303486.ref052","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","article-title":"Staging of Alzheimer\u2019s disease-related neurofibrillary changes","volume":"16","author":"H Braak","year":"1995","journal-title":"Neurobiol Aging"},{"issue":"4","key":"pone.0303486.ref053","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"H Braak","year":"2006","journal-title":"Acta Neuropathol (Berl)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0303486","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T19:03:11Z","timestamp":1738868591000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0303486"}},"subtitle":[],"editor":[{"given":"Maud","family":"Gratuze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0303486","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]}}}